Prevalence, Resource Utilization, and Economic Impact of Kidney Function and Proteinuria in Patients With Focal Segmental GlomerulosclerosisByMark E. Bensink, PhD,Kamlesh M. Thakker, BPharm, PhD,Edgar V. Lerma, MD,Richard M. Lieblich, RPh,C. Martin Bunke, MD,Kaijun Wang, PhD,Wu Gong, MS,Andrew Rava, MPH,Michael V. Murphy, BA,David Oliveri, BS,Diana T. Amari, PhD,David Cork, PhD,Juan Carlos Q. Velez, MDMay 8th 2026
Review of the Clinical, Humanistic, and Economic Burden of Focal Segmental GlomerulosclerosisByMark E. Bensink, PhD,Chris Gisler, MD,Colin Navickas, BEngMay 8th 2026
